G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency. (Q39331096)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

title

G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Jae Hong Im

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Thomas Tapmeier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Lukxmi Balathasan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Annamaria Gal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Sabira Yameen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Sally Hill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Sean Smart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Olivier Noterdaeme

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Matthew Kelly

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Michael Brady

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Weili Fu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Karoline Kruse

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Eric J Bernhard

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

Ruth J Muschel

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

3 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

International Journal of Cancer

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

315-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22699974 AND SRC:MED&resulttype=core&format=json

Angiogenesis as a therapeutic target

5 February 2020

cites work

1 reference

Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way.

21 January 2018

1 reference

Adverse effects of anticancer agents that target the VEGF pathway

21 January 2018

1 reference

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

Angiopoietins: a link between angiogenesis and inflammation.

21 January 2018

1 reference

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

21 January 2018

1 reference

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation

21 January 2018

1 reference

Angiopoietin-2 is implicated in the regulation of tumor angiogenesis

21 January 2018

1 reference

Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma

21 January 2018

1 reference

Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer

21 January 2018

1 reference

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

21 January 2018

1 reference

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

21 January 2018

1 reference

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

21 January 2018

1 reference

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

21 January 2018

1 reference

The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism

21 January 2018

1 reference

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

21 January 2018

1 reference

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.

21 January 2018

1 reference

The NG2 proteoglycan: past insights and future prospects

21 January 2018

1 reference

Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player

21 January 2018

1 reference

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

21 January 2018

1 reference

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

21 January 2018

1 reference

Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis

21 January 2018

1 reference

The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation.

21 January 2018

1 reference

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

Neutrophils: key mediators of tumour angiogenesis

21 January 2018

1 reference

G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands

21 January 2018

1 reference

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation

21 January 2018

1 reference

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

21 January 2018

1 reference

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G Ly6C granulocytes

21 January 2018

1 reference

Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice

21 January 2018

1 reference

In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice

21 January 2018

1 reference

21 January 2018

IL-13 effector functions

1 reference

High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor alpha fusion protein, in metastatic melanoma and colorectal cancer

21 January 2018

1 reference

Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance

21 January 2018

1 reference

Bone marrow derived cells in the tumour microenvironment contain cells with primitive haematopoietic phenotype

21 January 2018

1 reference

A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships

21 January 2018

1 reference

Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.

21 January 2018

1 reference

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

21 January 2018

1 reference

Hepatic expression of ANG2 RNA in metastatic colorectal cancer

21 January 2018

1 reference

Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer.

21 January 2018

1 reference